With a mean age of 21 years 197 women at risk for an infection with Chlamydia trachomatis (CT) had a urinary sample (20 ml first-void urine, minimum 4 hours from prior mictuation) analysed with an enzyme immunoassay (IDEIA-III) for the detection of CT. They also had samples taken from both cervix and urethra for cultivation on McCoy's cells and testing with an enzyme immunoassay (Chlamydiazyme), plus verification of positive samples in the enzyme immunoassay (EIA) with monoclonal antibodies against CT. The urethral samples were compared against the urinary samples with regard to sensitivity and specificity in detecting CT. Women with a positive culture for CT and/or a positive verified EIA from either the cervix or the urethra, were regarded as "true" infections with CT. The prevalence of CT was 12-2%. The urinary EIA sample had a sensitivity of 84% whereas the urethral EIA sample had a sensitivity of 57%. The specificity was 98% and 100% for the urinary samples, and the urethral samples respectively. It is concluded that the urinary sample is superior to the urethral sample, and that the urinary sample could be used for screening programs, to detect CT among women.
Introduction
To detect Chlamydia trachomatis (CT) infections in women samples for culturing or direct detection are usually taken from cervix and urethra. Some women experience pain when the urethral sample is taken, and some have symptoms of urethritis afterwards. Because of this some young women are reluctant to have samples taken, particularly if they have no symptoms of disease. Women infected with CT are often asymptomatic.1-3 Infections with CT may cause serious complications like salpingitis, increased risk of ectopic pregnancy and infertility.' It is therefore of great importance to find and treat these asymptomatic women. Owing to the invasive sampling procedure, screening programmes are difficult to perform. Earlier, urinary specimens had been compared with urethral samples to detect CT using the cell culture technique. The sensitivity for the urinary samples was however not acceptable.7 Recently a method has been described to detect CT with enzyme immunoassay (EIA) in urinary samples from men.>" The aim of this study was to examine women at risk for CT infection with the standard invasive sampling from the cervix and the urethra and to compare with a urinary sample, for the detection of CT.
Subjects and methods One hundred and ninety seven women, either pregnant, wanting an abortion or attending the family planning clinic were studied. Their mean age was 21 years (range 16-46). The women were asked to leave a urinary sample (20 ml first-void urine, minimum 4 hours from prior mictuation). The invasive samples were then taken from urethra and endocervix after the cervix had been wiped clean with a large cotton swab. Samples for cultivation on McCoy's cells were taken with ENT swabs and samples for enzyme immunoassay (Chlamydiazyme, Abbott) were taken with EZE swabs. All the positive samples in the enzyme immunoassays had to be verified in immunofluorescence microscope with CT monoclonal antibodies (Syva, Micro Trak) before they were regarded as truly positive. The urinary samples (20 ml) were centrifuged at 3000 g for 20 minutes; the sediment was resuspended in 1 ml disruption buffer and analysed with enzyme immunoassay (IDEIA-III, Novo Bio labs) in accordance with the manufacturers instructions. Positive samples were verified as above. The criteria for a CT infection in the urethra or in the cervix, was a positive culture and/or a positive Chlamydiazyme test positively verified with CT monoclonal antibodies.
Results
Of the 197 women entered in the study 23 (11-6%) had positive endocervical CT cultures. Twenty-four (prevalence 12 2%) women were positive for CT in one or more of the samples (cultures from cervix and urethra and EIA cervix and urethra). Twenty 
